Readers of this space know that the investment bias is toward large-cap companies with demonstrated business models and a competitive advantage in established markets, preferably with a favorable global trend as a support. With this in mind, Intel is worth an evaluation.

Intel (NASDAQ: INTC) is the world's largest semiconductor maker, as measured by revenue and unit shipments, and is the dominant microprocessor manufacturer for personal computers.

In general, analysts expect F2008 revenue to increase 5-7%, after an 8% increase in F2007. The conventional wisdom in semiconductor analysis land now suggests that smaller/more-portable computer forms and media-rich PDAs will drive strong PC and PDA microprocessor sales.

Further, Intel remains the leader in next-generation chip technology, and its product mix remains superior. Gross margins should increase, as a result of lower unit costs and improved plant utilization. Also, high-performance chip prices should increase noticeably.

Readers of this space know that one of my preferred sectors has been in oil and oil services.

Further, with oil now well above $110 per barrel, one may think that all of the attractive oil plays have been bid up. Indeed, most have, but one that may represent an opportunity, for high-risk investors only, is TXCO Resources.

TXCO Resources (NASDAQ: TXCO) acquires, explores, develops, and produces oil and gas properties. The company's primary focus is on developing oil and gas reserves on properties located in Texas. The company's reserve mix is 54% oil and 46% natural gas.

In general, analysts expect TXCO's revenue to increase by better than 20% in F2008 after an impressive 30% gain in F2007.

Further, analysts also like the fact that TXCO's proved reserves increased substantially, via drilling and acquisition, to 91.8 billion CFE at the end of F2007, from 41.4 billion CFE at the end of F2006. The Reuters F2008/F2009 EPS consensus estimates for TXCO are 57 cents / 75 cents.

The choppy/consolidating (or perhaps worse) market conditions sometimes give the impression that growth plays do not exist, but that is not the case, and one growth company worth reviewing is Western Digital Corp.

Western Digital Corp. (NYSE: WDC) is one of largest, independent hard drive manufacturers in the world.

In general, analysts see 35%-45% revenue growth in FY 2008, reflecting the Komag acquisition, and solid PC hard drive and DVD hard drive demand.

The choppy/consolidating (or perhaps worse) market conditions sometimes give the impression that growth plays do not exist, but that is not the case, and one growth company worth reviewing is Texas Instruments.

Texas Instruments (NYSE: TXN) is the world's third largest semiconductor company, with operations in more than 25 countries.

In general, analysts see TXN's revenue increasing 5-8% in 2008, with the company likely to increase its leading market share in the analog segment; a smaller annual revenue increase is expected in the handset digital segment.
Further, analysts say TXN is well positioned to benefit from increasing use of higher-end analog products. Meanwhile, higher plant utilization and a recent restructuring should aid TXN's bottom line. The Reuters F2008/F2009 EPS consensus estimates for TXN are $2.09/$2.31.

The market's choppy/consolidating pattern characterized much of the last 5 months of 2007. However, with the start of 2008 and the entrance of new-year money flows, it's prudent to add a growth play or two, to be well-positioned for improving economic conditions, should they occur, and a growth stock worth a review is Synchronoss Tech.

Synchronoss Technologies, Inc. Tech (Nasdaq: SNCR) provides software and services that communications service providers use to manage tasks such as service activation and customer transactions, including additions, subtractions, and changes to service plans.

Analysts see 2008 revenue advancing 40-50% following a likely 60-70% revenue gain in 2007. Subscriber growth should be strong, with solid margins.

For long-term plays, the preferred investment is a company with a demonstrated business model (10 years), in an established market, with an average total annual return on equity of 20% during that span.

To be sure, First Solar (NYSE: FSLR) does not fit that profile, but it's worth a review, given both macro fundamentals and the company's outlook. Note: Underscoring, this is a high-risk stock.

First Solar uses an advanced, thin-film technology that uses cadmium telluride semiconductor material to convert sunlight into electricity. With a global polycrystalline silicon shortage holding back some producers of solar cells, First Solar's glass as substrate, coated with cadmium telluride can march ahead, while others await their raw materials.

Way back in the 20th century, rails were hardly considered a growth play. But with consistent demand for commodities and raw materials, along with the (seemingly) continual rise in truck transport costs, the rails are becoming a primary shipment mode, which means good things -- long-term -- for rail companies.

Among the rails, CSX Corp (NYSE: CSX) is a company worth a review. CSX operates the largest rail network in the eastern United States, with a 22,000-mile network in 23 states and two Canadian provinces.

In general, analysts see CSX's revenue growth slowing somewhat in 2007, offset by better margins, pricing power (including expired contracts repricing) and improved asset utilization.

Further, coal traffic may slow heading into 2008, but intermodal traffic is expected to remain solid. Numerous infrastructure improvements and capacity increases should improve CSX's delivery times and reduce dwell times. In addition, trading around $42 with a p/e of 16, CSX currently is somewhat of a bargain, as Wall Street has discounted CSX's share for a U.S. economic slowdown, taking the stock down about 20% from a $52-high reached this summer.

Normally, when a company reports a quarter with numbers as impressive as Crocs (NASDAQ: CROX) did, you expect the share price to rise. On September 30, Crocs reported third quarter earnings per share of $0.66 versus expectations of $0.63 and revenue of $256.3 million, in-line with expectations. The death knell was the dreaded words "in-line."

The company had been on a run of exceeding Street expectations by quite a bit. The shares were hit very hard on Thursday coming down from $74 to $47, exacerbated by a 360-point decline in the Dow.

The numbers that Crocs reported were actually quite impressive as revenue were up 130% over last year's 3rd quarter and earnings were up 144% for the same period. The gross margins expanded from 58% to 60.4%, while the ever-important operating margin actually hit above 30%. Young growth companies are not supposed to hit operating margins of 30%. It is virtually unheard of.

The other important piece of news was the company raising its 2008 guidance for earnings in the $2.65-2.70 range. With 2007 looking to be at $1.96, the growth for 2008 would be 35-40%. The stock market reaction was a tremendous overreaction, and the shares are now selling at quite a discount to its growth rate and operating margin level.

Typically, the market is comfortable assigning one P/E point to one point of growth or one point of operating margin. With the growth rate and the operating margins north of 30%, Crocs could support a 30 PE of its 2008 earnings expectations or $81 per share. Assigning a premium over the 30 PE would lift the shares even higher.

"A new study on stem cell research is mind-boggling," notes emerging growth expert Toby Smith in support of his recommendation for Geron Corp. (NASDAQ: GERN).

The growth stock expert and editor of ChangeWave Investing explains, "Geron reported its scientists and collaborators have demonstrated that human embryonic stem cell (hESC)-derived cardiomyocytes improve heart function when transplanted after myocardial infarction.

"Published online on Aug. 26, in Nature Biotechnology, the landmark study is the first to document the potential clinical utility of regenerating damaged heart muscle by injecting hESC-derived cardiomyocytes directly into the site of the infarct.

"In addition, the research confirms the effectiveness of a scalable production system that enables Geron to manufacture the cardiomyocytes for use in ongoing large animal studies and, ultimately, testing in humans."

"In the current volatile market, you can't go wrong by making your portfolio more defensive," says Glenn Rogers, who notes he has been "on the hunt for stocks that are fairly bulletproof."

One such stock, according to the analyst with Internet Wealth Builder, is Diageo PLC (NYSE: DEO). He says, ""London-based Diageo is the largest international manufacturer and distributor in the beverage alcohol industry, which is virtually recession-proof."

Many of its brands, he notes, will be immediately recognizable: Smirnoff, Guinness, Johnnie Walker, Captain Morgan, Jose Cuervo, Bushmills, J&B Scotch, and our own Crown Royal. In fact, he observes, 17 of the company's brands are among the top 100 premium spirit brands in the world.

Rogers explains, "Its strategy is to drive organic growth by taking leadership positions in every category in which it competes. The company also looks to exploit opportunities for growth in such key emerging markets as China, India, Russia, and Brazil."

Yesterday Google Inc. (NASDAQ: GOOG) hit an all time high -- up six-fold -- a bit under three years after its $85 IPO. The proximate cause of the latest rise is a deal with salesforce.com, Inc. (NYSE: CRM). The deal could create more opportunities for Google to connect with salesforce's 32,300 customers -- each of whom is a potential advertiser who has not previously tried running online marketing campaigns through Google's automated system

I've posted bullishly on Google for a while -- most recently on Memorial Day. That's when Steve Mandel, head of $8 billion hedge fund Lone Pine Capital, said he believes that Google's growth potential is not fully understood by investors because its core market of paid search is still in "its early innings."

Google is getting more expensive but I suspect not overvalued. I don't know Mandel's earnings forecasts for the company; however last week it traded at $497.91 a moderate PEG of 1.38 -- reflecting a P/E of 43.3 on 24 analysts' consensus 2008 earnings growth of 31.4% to $17.45. That PEG is higher now -- 1.49 reflecting a higher P/E of 46.5 on a slightly lower 24 analysts' consensus 2008 earnings growth of 31.21% to $17.43.

I think Google could hit $1,000 because of the growth potential in the company's 84 different businesses which do not yet generate revenues and revenues from future partnerships like the one with salesforce.

Do you think it's time to buy or sell Google?

Peter Cohan is President of Peter S. Cohan & Associates, a management consulting and venture capital firm. He also teaches management at Babson College and edits The Cohan Letter. He has no financial interest in the securities mentioned in this post.

Google Inc. (NASDAQ: GOOG) reported a great quarter and once again shattered analysts best guess estimates across the board. The stock market is jubilant this morning on that and other favorable earnings reports recently as the Dow Jones Industrial Average, DJIA, is up over 100 points, threatening 13,000.

Google was up yesterday in after market trading and is currently (11:30 a.m. EST) trading at $488, up 3.5% from yesterday's close.

In my post yesterday, Serious Money: You asked about Intuitive Surgical?, I blogged of my own venture into a dramatic growth stock and even went as far as to outline why Intuitive Surgical (NASDAQ: ISRG) was the superior investment compared to Google.

While Google has taken the market by storm and grabbed all the attention, ISRG is currently trading up 10.3% to $133.66 on an equally astounding earnings report, beating estimates by 9 cents per share. Both companies are charging into the future with great promise, leading their respective sectors and leaving all estimates behind in the dust. GOOG and ISRG look unstoppable at the moment, but investors should be careful with all this euphoria.

If you are not familiar with ISRG, perhaps you should take a look.

Sheldon Liber is the CEO of a small private investment company and the vice president for design and research at an architecture & planning firm. Check out his other posts for BloggingStocks here.

In his small cap growth oriented newsletter, Upside, editor Richard Moroney uses a ranking system known as Quadrix that assesses a stock based on a wide variety of fundamental, financial and technical factors.

A rarity in this system, Chaparral Steel (NASDAQ: CHAP) earns a 100 out of 100 rating. Chaparral, he notes, is the second-largest supplier of structural steel in North America.

The firm specializes in structural beams and steel bars, which are used for commercial construction. Its two minimill plants, he notes, use recycled steel that comes primarily from shredded automobiles.

Looking ahead, he says, "the company should benefit from robust demand, decent pricing, and strict cost controls." In addition, he notes that last November the company paid its first quarterly dividend, initially set at $0.10 per share.

Further, he observes, management has authorized a share-repurchase program of to $100 million. Earnings estimates for this year and next have trended higher and for fiscal 2007 ending May, he notes that consensus estimates project per-share profits will be up 50% to $4.99.

He concludes, "With the maximum overall Quadrix score of 100, Chaparral is being added to our coverage as a Buy."

For more stock picks from the leading financial newsletter advisors, visit Steven Halpern's free daily website, TheStockAdvisors.com.

Anglo American plc (ADR) (NASDAQ: AAUK) is really a United Kingdom based company with no American history, although a long history it has. We are continuing our search for value stocks as we very methodically place new money in the market. Our first purchase was an old favorite: Washington Mutual, Inc. (NYSE:WM). We recently acquired it at $40 per share after following it down from $47. Yesterday, Georges Yared posted Washington Mutual: A ridiculously cheap pick in sub-prime panic and we agree with him totally....take a look at the depressed price, the 5.3% yield and more.

We like the Anglo American company and the stock for numerous reasons. It came to our attention initially because it has a 1.17 price-to-sales ratio (P/S), a price-to-book ratio of 1.29 (P/B), and a yield over 2%. To go along with those metrics it has been growing at 15% to 20% over the last few years as the world demand for gold and platinum has increased. You can check out the fundamentals at AOL Money & Finance as a starting point for your own research if you are interested.

When looking for growth, Richard Moroney, editor of Dow Theory Forecast, notes that he avoids speculative and expensive "hypergrowth" stories and prefers to focus on steady growers with reasonable valuations and the ability to exceed expectations."

Among his current favorite growth ideas is Nike Inc. (NYSE:NKE). He explains, "The company hopes to increase its annual sales to $23 billion by fiscal 2011 ending May, up from $15 billion in fiscal 2006, as part of a five-year growth strategy announced in February."

He notes that the firm's plans include expanding its retail presence with the addition of 100 new company stores worldwide over the next three years, half in the U.S.

In addition, the company is expected to divide the Nike brand into six categories -- soccer, basketball, running, men's training, women's fitness, and sports culture -- to better target consumers. Moroney says, "Management expects to reach its sales growth target without the help of new acquisitions."